Marijuana is the most widely consumed recreational drug worldwide, which raises concerns for its potential effects on fertility. Many aspects of human male reproduction can be modulated by cannabis-derived extracts (cannabinoids) and their endogenous counterparts, known as endocannabinoids (eCBs). These latter molecules act as critical signals in a variety of physiological processes through receptors, enzymes and transporters collectively termed the endocannabinoid system (ECS). Increasing evidence suggests a role for eCBs, as well as cannabinoids, in various aspects of male sexual and reproductive health. Although preclinical studies have clearly shown that ECS is involved in negative modulation of testosterone secretion by acting both at central and testicular levels in animal models, the effect of in vivo exposure to cannabinoids on spermatogenesis remains a matter of debate. Furthermore, inconclusive clinical evidence does not seem to support the notion that plant-derived cannabinoids have harmful effects on human sexual and reproductive health. An improved understanding of the complex crosstalk between cannabinoids and eCBs is required before targeting of ECS for modulation of human fertility becomes a reality.
Marijuana has the highest consumption rate of any recreational drug in the Western world.
Endocannabinoids and their receptors, enzymes and transporters, which together form the endocannabinoid system (ECS), are present in various components of the male reproductive tract, including male genital glands, testis and sperm.
Preclinical studies have shown that the ECS is involved in negative modulation of testosterone secretion by acting at both central and testicular levels.
As yet, clinical data are insufficient to conclude that cannabinoids have a harmful effect on human male sexual function and fertility.
Although cannabinoid receptors are present in the testes and sperm, the effects of cannabinoid exposure on spermatogenesis largely remain to be clarified.
The ECS has the potential to provide new drug targets in male reproductive disorders, and its components might be useful as biomarkers of male infertility.
Subscribe to Journal
Get full journal access for 1 year
only $4.92 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
United Nations Office on Drugs and Crime. Executive summary: conclusions and policy implications. UNODC https://www.unodc.org/wdr2017/field/Booklet_1_EXSUM.pdf (2017).
Substance Abuse Mental Health Services Administration. Results from the 2013 national survey on drug use and health: summary of national findings. US Department of Health and Human Services http://www.samhsa.gov/data/sites/default/files/NSDUHresultsPDFWHTML2013/Web/NSDUHresults2013.htm#ch2 (2013).
Arcview. The State of Legal Marijuana Markets 5th edn (Arcview, 2017).
Friedman, D., French, J. & Maccarrone, M. Safety, efficacy, and mechanisms of action of cannabinoids in neurological disorders. Lancet Neurol. 18, 504–512 (2019).
Cohen, K., Weizman, A. & Weinstein, A. Positive and negative effects of cannabis and cannabinoids on health. Clin. Pharmacol. Ther. 105, 1139–1147 (2019).
du Plessis, S. S., Agarwal, A. & Syriac, A. J. Marijuana, phytocannabinoids, the endocannabinoid system, and male fertility. Assist. Reprod. Genet. 32, 1575–1588 (2015).
Maccarrone, M. et al. Endocannabinoid signaling at the periphery: 50 years after THC. Trends Pharmacol. Sci. 36, 277–296 (2015).
Payne, K. S., Mazur, D. J., Hotaling, J. M. & Pastuszak, A. W. Cannabis and male fertility: a systematic review. J. Urol. 202, 674–681 (2019).
Nassan, F. L. et al. Marijuana smoking and markers of testicular function among men from a fertility centre. Hum. Reprod. 34, 715–723 (2019).
El Sohly, M. & Gul, W. in Handbook of Cannabis (ed. Pertwee R. G.) 3–22 (Oxford Univ. Press, 2014).
World Health Organization. Expert Committee on Drug Dependence, Section 1: Chemistry Cannabis plant and cannabis resin (WHO, 2018).
Morales, P., Hurst, D. P. & Reggio, P. H. Molecular targets of the phytocannabinoids: a complex picture. Prog. Chem. Org. Nat. Prod. 103, 103–131 (2017).
Huestis, M. A. Human cannabinoid pharmacokinetics. Chem. Biodivers. 4, 1770–1804 (2007).
Small, E. Cannabis: a complete guide (CRC, 2017).
Elliott, D. M., Singh, N., Nagarkatti, M. & Nagarkatti, P. S. Cannabidiol attenuates experimental autoimmune encephalomyelitis model of multiple sclerosis through induction of myeloid-derived suppressor cells. Front. Immunol. 9, 1782 (2018).
Carvalho, R. K. et al. Chronic cannabidiol exposure promotes functional impairment in sexual behavior and fertility of male mice. Reprod. Toxicol. 81, 34–40 (2018).
Pertwee, R. G. et al. International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB1 and CB2. Pharmacol. Rev. 62, 588–631 (2010).
Wang, H., Dey, S. K. & Maccarrone, M. Jekyll and Hyde: two faces of cannabinoid signaling in male and female fertility. Endocr. Rev. 27, 427–448 (2006).
Fezza, F. et al. Endocannabinoids, related compounds and their metabolic routes. Molecules 19, 17078–17106 (2014).
Rapino, C., Battista, N., Bari, M. & Maccarrone, M. Endocannabinoids as biomarkers of human reproduction. Hum. Reprod. Update 20, 501–516 (2014).
Barbonetti, A. et al. 2-arachidonoylglycerol levels are increased in leukocytospermia and correlate with seminal macrophages. Andrology 5, 87–94 (2017).
Maccarrone, M. Metabolism of the endocannabinoid anandamide: open questions after 25 years. Front. Mol. Neurosci. 10, 166 (2017).
Francavilla, F. et al. Characterization of the endocannabinoid system in human spermatozoa and involvement of transient receptor potential vanilloid 1 receptor in their fertilizing ability. Endocrinology 150, 4692–4700 (2009).
Lewis, S. E. M. et al. Differences in the endocannabinoid system of sperm from fertile and infertile men. PLoS ONE 7, e47704 (2012).
Maccarrone, M. et al. Anandamide activity and degradation are regulated by early postnatal aging and follicle-stimulating hormone in mouse Sertoli cells. Endocrinology 144, 20–28 (2003).
Rossi, G. et al. Follicle-stimulating hormone activates fatty acid amide hydrolase by protein kinase A and aromatase-dependent pathways in mouse primary Sertoli cells. Endocrinology 148, 1431–1439 (2007).
Okamoto, Y., Tsuboi, K. & Ueda, N. Enzymatic formation of anandamide. Vitam. Horm. 81, 1–24 (2009).
McKinney, M. K. & Cravatt, B. F. Structure and function of fatty acid amide hydrolase. Annu. Rev. Biochem. 74, 411–432 (2005).
Bisogno, T. et al. Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain. J. Cell Biol. 163, 463–468 (2003).
Dinh, T. P. et al. Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc. Natl Acad. Sci. USA 99, 10819–10824 (2002).
Miller, M. R. et al. Unconventional endocannabinoid signaling governs sperm activation via the sex hormone progesterone. Science 352, 555–559 (2016).
Chicca, A., Marazzi, J., Nicolussi, S. & Gertsch, J. Evidence for bidirectional endocannabinoid transport across cell membranes. J. Biol. Chem. 41, 34660–34682 (2012).
Maccarrone, M., Dainese, E. & Oddi, S. Intracellular trafficking of anandamide: new concepts for signaling. Trends Biochem. Sci. 35, 601–608 (2010).
Wang, J. et al. Expression and secretion of N-acylethanolamine-hydrolysing acid amidase in human prostate cancer cells. J. Biochem. 144, 685–690 (2008).
Bakali, E. et al. Distribution and function of the endocannabinoid system in the rat and human bladder. Int. Urogynecol. J. 24, 855–863 (2013).
Kondo, S. et al. Accumulation of various N-acylethanolamines including N-arachidonoylethanolamine (anandamide) in cadmium chloride-administered rat testis. Arch. Biochem. Biophys. 354, 303–310 (1998).
Godlewski, G., Offertáler, L., Wagner, J. A. & Kunos, G. Receptors for acylethanolamides–GPR55 and GPR119. Prostaglandins Other Lipid Mediat. 89, 105–111 (2009).
Ückert, S. et al. Expression and distribution of key proteins of the endocannabinoid system in the human seminal vesicles. Andrologia 50, 12875 (2018).
Murphy, L. L., Steger, R. W., Smith, M. S. & Bartke, A. Effects of delta-9-tetrahydrocannabinol, cannabinol and cannabidiol, alone and in combinations, on luteinizing hormone and prolactin release and on hypothalamic neurotransmitters in the male rat. Neuroendocrinology 52, 316–321 (1990).
Wenger, T., Ledent, C., Csernus, V. & Gerendai, I. The central cannabinoid receptor inactivation suppresses endocrine reproductive functions. Biochem. Biophys. Res. Commun. 284, 363–368 (2001).
Scorticati, C. et al. The inhibitory effect of anandamide on luteinizing hormone-releasing hormone secretion is reversed by estrogen. Proc. Natl Acad. Sci. USA 101, 11891–11896 (2004).
Wenger, T., Fernández-Ruiz, J. J. & Ramos, J. A. Immunocytochemical demonstration of CB1 cannabinoid receptors in the anterior lobe of the pituitary gland. J. Neuroendocrinol. 11, 873–878 (1999).
Wittmann, G. et al. Distribution of type 1 cannabinoid receptor (CB1)-immunoreactive axons in the mouse hypothalamus. J. Comp. Neurol. 503, 270–279 (2007).
Wenger, T., Rettori, V., Snyder, G. D., Dalterio, S. & McCann, S. M. Effects of delta-9-tetrahydrocannabinol on the hypothalamic-pituitary control of luteinizing hormone and follicle-stimulating hormone secretion in adult male rats. Neuroendocrinology 46, 488–493 (1987).
Gammon, C. M. et al. Regulation of gonadotropin-releasing hormone secretion by cannabinoids. Endocrinology 146, 4491–4499 (2005).
Farkas, I. et al. Retrograde endocannabinoid signaling reduces GABAergic synaptic transmission to gonadotropin-releasing hormone neurons. Endocrinology 151, 5818–5829 (2010).
Watanabe, M., Fukuda, A. & Nabekura, J. The role of GABA in the regulation of GnRH neurons. Front. Neurosci. 8, 387 (2014).
Todman, M. G., Han, S.-K. & Herbison, A. E. Profiling neurotransmitter receptor expression in mouse gonadotropin-releasing hormone neurons using green fluorescent protein-promoter transgenics and microarrays. Neuroscience 132, 703–712 (2005).
Cristino, L. et al. Immunohistochemical localization of cannabinoid type 1 and vanilloid transient receptor potential vanilloid type 1 receptors in the mouse brain. Neuroscience 139, 1405–1415 (2006).
Cacciola, G. et al. Expression of type-1 cannabinoid receptor during rat postnatal testicular development: possible involvement in adult leydig cell differentiation. Biol. Reprod. 79, 758–765 (2008).
Jakubovic, A., McGeer, E. G. & McGeer, P. L. Effects of cannabinoids on testosterone and protein synthesis in rat testis Leydig cells in vitro. Mol. Cell. Endocrinol. 15, 41–50 (1979).
List, A., Nazar, B., Nyquist, S. & Harclerode, J. The effects of delta9-tetrahydrocannabinol and cannabidiol on the metabolism of gonadal steroids in the rat. Drug Metab. Dispos. 5, 268–272 (1977).
Banerjee, A., Singh, A., Srivastava, P., Turner, H. & Krishna, A. Effects of chronic bhang (cannabis) administration on the reproductive system of male mice. Birth Defects Res. B Dev. Reprod. Toxicol. 92, 195–205 (2011).
Fujimoto, G. I., Morrill, G. A., O’Connell, M. E., Kostellow, A. B. & Retura, G. Effects of cannabinoids given orally and reduced appetite on the male rat reproductive system. Pharmacology 24, 303–313 (1982).
McDonald, C. A. et al. Follicle-stimulating hormone-induced aromatase in immature rat Sertoli cells requires an active phosphatidylinositol 3-kinase pathway and is inhibited via the mitogen-activated protein kinase signaling pathway. Mol. Endocrinol. 20, 608–618 (2006).
Grimaldi, P. et al. The faah gene is the first direct target of estrogen in the testis: role of histone demethylase LSD1. Cell. Mol. Life Sci. 69, 4177–4190 (2012).
Chioccarelli, T. et al. Cannabinoid receptor 1 influences chromatin remodeling in mouse spermatids by affecting content of transition protein 2 mRNA and histone displacement. Endocrinology 151, 5017–5029 (2010).
Dixit, V. P., Gupta, C. L. & Agrawal, M. Testicular degeneration and necrosis induced by chronic administration of cannabis extract in dogs. Endokrinologie 69, 299–305 (1977).
Lewis, S. E. M. et al. Long-term use of HU210 adversely affects spermatogenesis in rats by modulating the endocannabinoid system. Int. J. Androl. 35, 731–740 (2012).
Berryman, S. H., Anderson, R. A., Weis, J. & Bartke, A. Evaluation of the co-mutagenicity of ethanol and Δ9-tetrahydrocannabinol with Trenimon. Mutat. Res. 278, 47–60 (1992).
López-Cardona, A. P. et al. Effect of chronic THC administration in the reproductive organs of male mice, spermatozoa and in vitro fertilization. Biochem. Pharmacol. 157, 294–303 (2018).
Pagotto, U. et al. Normal human pituitary gland and pituitary adenomas express cannabinoid receptor type 1 and synthesize endogenous cannabinoids: first evidence for a direct role of cannabinoids on hormone modulation at the human pituitary level. J. Clin. Endocrinol. Metab. 86, 2687–2696 (2001).
Vescovi, P. P. et al. Chronic effects of marihuana smoking on luteinizing hormone, follicle-stimulating hormone and prolactin levels in human males. Drug Alcohol. Depend. 30, 59–63 (1992).
Kolodny, R. C., Masters, W. H., Kolodner, R. M. & Toro, G. Depression of plasma testosterone levels after chronic intensive marihuana use. N. Engl. J. Med. 290, 872–874 (1974).
Mendelson, J. H., Kuehnle, J., Ellingboe, J. & Babor, T. F. Plasma testosterone levels before, during and after chronic marihuana smoking. N. Engl. J. Med. 291, 1051–1055 (1974).
Cushman, P. Plasma testosterone levels in healthy male marijuana smokers. Am. J. Drug Alcohol Abuse 2, 269–275 (1975).
Gundersen, T. D. et al. Association between use of marijuana and male reproductive hormones and semen quality: a study among 1,215 healthy young men. Am. J. Epidemiol. 182, 473–481 (2015).
Thistle, J. E. et al. Marijuana use and serum testosterone concentrations among U.S. males. Andrology 5, 732–738 (2017).
Rajanahally, S. et al. The relationship between cannabis and male infertility, sexual health, and neoplasm: a systematic review. Andrology 7, 139–147 (2019).
Elbendary, M. A., El-Gamal, O. M. & Salem, K. A. Analysis of risk factors for organic erectile dysfunction in Egyptian patients under the age of 40 years. J. Androl. 30, 520–524 (2009).
Aversa, A. et al. Early endothelial dysfunction as a marker of vasculogenic erectile dysfunction in young habitual cannabis users. Int. J. Impot. Res. 20, 566–573 (2008).
Johnson, S. D., Phelps, D. L. & Cottler, L. B. The association of sexual dysfunction and substance use among a community epidemiological sample. Arch. Sex. Behav. 33, 55–63 (2004).
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders 3rd edn (American Psychiatric Association, 1980).
Smith, A. M. A. et al. Cannabis use and sexual health. J. Sex. Med. 7, 787–793 (2010).
Allen, M. S. & Walter, E. E. Health-related lifestyle factors and sexual dysfunction: a meta-analysis of population-based research. J. Sex. Med. 15, 458–475 (2018).
Vallejo-Medina, P. & Sierra, J. C. Effect of drug use and influence of abstinence on sexual functioning in a Spanish male drug-dependent sample: a multisite study. J. Sex. Med. 10, 333–341 (2013).
Androvicova, R. et al. Endocannabinoid system in sexual motivational processes: is it a novel therapeutic horizon? Pharmacol. Res. 115, 200–208 (2017).
Tart, C. T. Marijuana intoxication common experiences. Nature 226, 701–704 (1970).
Halikas, J., Weller, R. & Morse, C. Effects of regular marijuana use on sexual performance. J. Psychoactive Drugs 14, 59–70 (1982).
Sun, A. J. & Eisenberg, M. L. Association between marijuana use and sexual frequency in the United States: a population-based study. J. Sex. Med. 14, 1342–1347 (2017).
Murphy, S. K. et al. Cannabinoid exposure and altered DNA methylation in rat and human sperm. Epigenetics 13, 1208–1221 (2018).
Close, C. E., Roberts, P. L. & Berger, R. E. Cigarettes, alcohol and marijuana are related to pyospermia in infertile men. J. Urol. 144, 900–903 (1990).
Pacey, A. A. et al. Modifiable and non-modifiable risk factors for poor sperm morphology. Hum. Reprod. 29, 1629–1636 (2014).
Tremellen, K. Oxidative stress and male infertility–a clinical perspective. Hum. Reprod. Update 14, 243–258 (2008).
Castellini, C. et al. Relationship between leukocytospermia, reproductive potential after assisted reproductive technology, and sperm parameters: a systematic review and meta-analysis of case-control studies. Andrology 8, 125–135 (2020).
World Health Organization. WHO Laboratory Manual for the Examination and Processing of Human Semen and Sperm-Cervical Mucus Interaction 5th edn (WHO, 2010).
Kasman, A. M., Thoma, M. E., McLain, A. C. & Eisenberg, M. L. Association between use of marijuana and time to pregnancy in men and women: findings from the National Survey of Family Growth. Fertil. Steril. 109, 866–871 (2018).
Francavilla, F. et al. Within-subject variation of seminal parameters in men with infertile marriages. Int. J. Androl. 30, 174–181 (2007).
Rossato, M., Ion Popa, F., Ferigo, M., Clari, G. & Foresta, C. Human sperm express cannabinoid receptor Cb1, the activation of which inhibits motility, acrosome reaction, and mitochondrial function. J. Clin. Endocrinol. Metab. 90, 984–991 (2005).
Agirregoitia, E. et al. The CB2 cannabinoid receptor regulates human sperm cell motility. Fertil. Steril. 93, 1378–1387 (2010).
Schuel, H. et al. Evidence that anandamide-signaling regulates human sperm functions required for fertilization. Mol. Reprod. Dev. 63, 376–387 (2002).
Aquila, S. et al. A new role of anandamide in human sperm: focus on metabolism. J. Cell Physiol. 221, 147–153 (2009).
Aquila, S. et al. Rimonabant (SR141716) induces metabolism and acquisition of fertilizing ability in human sperm. Br. J. Pharmacol. 159, 831–841 (2010).
Amoako, A. A. et al. Anandamide modulates human sperm motility: implications for men with asthenozoospermia and oligoasthenoteratozoospermia. Hum. Reprod. 28, 2058–2066 (2013).
Francou, M. M. et al. Human sperm motility, capacitation and acrosome reaction are impaired by 2-arachidonoyl glycerol endocannabinoid. Histol. Histopathol. 32, 1351–1358 (2017).
Badawy, Z. S. et al. Cannabinoids inhibit the respiration of human sperm. Fertil. Steril. 91, 2471–2476 (2009).
Catanzaro, G., Rapino, C., Oddi, S. & Maccarrone, M. Anandamide increases swelling and reduces calcium sensitivity of mitochondria. Biochem. Biophys. Res. Commun. 388, 439–442 (2009).
Barbonetti, A. et al. Energetic metabolism and human sperm motility: impact of CB1 receptor activation. Endocrinology 151, 5882–5892 (2010).
Rossato, M. Endocannabinoids, sperm functions and energy metabolism. Mol. Cell. Endocrinol. 286, S31–S35 (2008).
Mukai, C. & Okuno, M. Glycolysis plays a major role for adenosine triphosphate supplementation in mouse sperm flagellar movement. Biol. Reprod. 71, 540–547 (2004).
Koppers, A. J., De Iuliis, G. N., Finnie, J. M., McLaughlin, E. A. & Aitken, R. J. Significance of mitochondrial reactive oxygen species in the generation of oxidative stress in spermatozoa. J. Clin. Endocrinol. Metab. 93, 3199–3207 (2008).
Barbonetti, A. et al. Involvement of cannabinoid receptor-1 activation in mitochondrial depolarizing effect of lipopolysaccharide in human spermatozoa. Andrology 2, 502–509 (2014).
De Toni, L. et al. Heat sensing receptor TRPV1 is a mediator of thermotaxis in human spermatozoa. PLoS ONE 11, e0167622 (2016).
Martínez-León, E. et al. Fibronectin modulates the endocannabinoid system through the cAMP/PKA pathway during human sperm capacitation. Mol. Reprod. Dev. 86, 224–238 (2019).
Thomas, P. & Meizel, S. Phosphatidylinositol 4,5-bisphosphate hydrolysis in human sperm stimulated with follicular fluid or progesterone is dependent upon Ca2+ influx. Biochem. J. 264, 539–546 (1989).
Baldi, E. et al. Nongenomic activation of spermatozoa by steroid hormones: facts and fictions. Mol. Cell. Endocrinol. 308, 39–46 (2009).
Baggelaar, M. P., Maccarrone, M. & van der Stelt, M. 2-Arachidonoylglycerol: a signaling lipid with manifold actions in the brain. Prog. Lipid Res. 71, 1–17 (2018).
Amoako, A. A. et al. Relationship between seminal plasma levels of anandamide congeners palmitoylethanolamide and oleoylethanolamide and semen quality. Fertil. Steril. 102, 1260–1267 (2014).
Berdyshev, E. V., Schmid, P. C., Krebsbach, R. J. & Schmid, H. H. Activation of PAF receptors results in enhanced synthesis of 2-arachidonoylglycerol (2-AG) in immune cells. FASEB J. 15, 2171–2178 (2001).
Di Marzo, V. et al. Biosynthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in circulating and tumoral macrophages. Eur. J. Biochem. 264, 258–267 (1999).
Liu, J. et al. Lipopolysaccharide induces anandamide synthesis in macrophages via CD14/MAPK/phosphoinositide 3-kinase/NF-κB independently of platelet-activating factor. J. Biol. Chem. 278, 45034–45039 (2003).
The authors thank all the colleagues who have contributed over the years to our studies on the role of endocannabinoid signalling in human male reproductive events, at University of L’Aquila, Tor Vergata University of Rome, Campus Bio-Medico University of Rome, Santa Lucia Foundation of Rome, University of Teramo and Leicester University.
The authors declare no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Naturally occurring substances in the cannabis plant.
- Sunflower oil
The non-volatile oil pressed from the seeds of sunflower.
- Intracellular trafficking
A general and tightly regulated process used by a variety of molecules to cross the membranes of, and move inside, living cells.
Movement towards or away from a thermal stimulus.
- Orphan enzyme
An enzyme for which activity has been experimentally characterized but amino acid sequences are lacking.
About this article
Cite this article
Maccarrone, M., Rapino, C., Francavilla, F. et al. Cannabinoid signalling and effects of cannabis on the male reproductive system. Nat Rev Urol 18, 19–32 (2021). https://doi.org/10.1038/s41585-020-00391-8